Robert Smith

Robert Smith

Director/Board Member at CITIUS PHARMACEUTICALS, INC.

Net worth: - $ as of 2026-05-30

65 year
Health Technology
Commercial Services
Health Services

Profile

Mr. Robert J.
Smith
is an Independent Director at Citius Oncology, Inc. and an Independent Director at Citius Pharmaceuticals, Inc. He is on the Board of Directors at Citius Oncology, Inc., Citius Pharmaceuticals, Inc., Foundation For Cell & Gene Medicine and Alliance for Regenerative Medicine.
Mr. Smith was previously employed as a Senior Vice President-Global Gene Therapy Business by Pfizer Inc. and a Senior Vice President-Mergers & Acquisitions by Wyeth LLC.
He also served on the board at BioNJ, Inc., Life Sciences Pennsylvania, Ignite Immunotherapy, Inc. and Bamboo Therapeutics, Inc. He received his undergraduate degree from the University of Rochester and an MBA from the University of Rochester Simon Business School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
-.--%
2026-05-21 0 ( -.--% ) - $ 2026-05-30
2026-02-12 0 ( -.--% ) - $ 2026-05-30

Robert Smith active positions

CompaniesPositionStart
CITIUS PHARMACEUTICALS, INC. Director/Board Member 2024-03-11
Director/Board Member 2017-12-31
Foundation For Cell & Gene Medicine
Director/Board Member 2018-12-31

Former positions of Robert Smith

CompaniesPositionEnd
PFIZER INC. Corporate Officer/Principal 2023-12-31
Director/Board Member 2019-09-30
Director/Board Member 2016-07-31
Corporate Officer/Principal 2009-09-30
Director/Board Member -
See the detail of Robert Smith's experience

Training of Robert Smith

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

64

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Services

Consumer Services

Health Technology

Health Technology

Foundation For Cell & Gene Medicine

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!